Clinical Trial Update: A Study of Dapagliflozin in Chinese Adult Patients With Chronic Kidney Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating dapagliflozin in Chinese adults with chronic kidney disease is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Kidney Disease | Phase 4 | Status: ACTIVE_NOT_RECRUITING